Abstract
The enormous health benefits of stopping smoking are now well established. Doctors have a vital role in motivating smokers and initiating quit attempts. The mainstay of National Health Service smoking cessation strategy should be the routine provision of brief opportunistic intervention in primary care, backed up by referral to a specialist smoking cessation service. There is an urgent need to increase substantially the numbers of smokers referred by general practitioners, other members of the primary care team, and those working in acute hospital trusts, to specialist smoking cessation services and for better channels of communication between the various agencies. Use of pharmacotherapy (nicotine replacement therapy or bupropion) in combination with behavioural support achieves higher cessation rates than either component alone and is the most effective way of helping smokers to stop. Smokers who quit often relapse and hence will need repeated help.
Full Text
The Full Text of this article is available as a PDF (84.8 KB).
Figure 1 .
Expected one year success rates from different interventions (biochemically validated abstinence).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bigelow G. E., Rand C. S., Gross J., Burling T. A., Gottlieb S. H. Smoking cessation and relapse among cardiac patients. NIDA Res Monogr. 1986;72:167–171. [PubMed] [Google Scholar]
- Caro J., Klittich W., McGuire A., Ford I., Norrie J., Pettitt D., McMurray J., Shepherd J. The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. BMJ. 1997 Dec 13;315(7122):1577–1582. doi: 10.1136/bmj.315.7122.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaspoz Jean-Michel, Coxson Pamela G., Goldman Paula A., Williams Lawrence W., Kuntz Karen M., Hunink M. G. Myriam, Goldman Lee. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002 Jun 6;346(23):1800–1806. doi: 10.1056/NEJM200206063462309. [DOI] [PubMed] [Google Scholar]
- Jönsson B., Johannesson M., Kjekshus J., Olsson A. G., Pedersen T. R., Wedel H. Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S) Eur Heart J. 1996 Jul;17(7):1001–1007. doi: 10.1093/oxfordjournals.eurheartj.a014994. [DOI] [PubMed] [Google Scholar]
- Kreuter M. W., Chheda S. G., Bull F. C. How does physician advice influence patient behavior? Evidence for a priming effect. Arch Fam Med. 2000 May;9(5):426–433. doi: 10.1001/archfami.9.5.426. [DOI] [PubMed] [Google Scholar]
- Muir J., Fuller A., Lancaster T. Applying the Sheffield tables to data from general practice. Br J Gen Pract. 1999 Mar;49(440):217–218. [PMC free article] [PubMed] [Google Scholar]
- Russell M. A., Wilson C., Taylor C., Baker C. D. Effect of general practitioners' advice against smoking. Br Med J. 1979 Jul 28;2(6184):231–235. doi: 10.1136/bmj.2.6184.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- West R., McNeill A., Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax. 2000 Dec;55(12):987–999. doi: 10.1136/thorax.55.12.987. [DOI] [PMC free article] [PubMed] [Google Scholar]